Current Take on Systemic Sclerosis Patients' Vaccination Recommendations

Systemic sclerosis (SSc) is a rare autoimmune inflammatory rheumatic disease. The prevalence of SSc ranges from 7 to 700 cases per million worldwide. Due to multiple organ involvement and constant inflammatory state, this group of patients presents an increased risk of infectious diseases. This pape...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccines (Basel) 2021-12, Vol.9 (12), p.1426
Hauptverfasser: Murdaca, Giuseppe, Noberasco, Giovanni, Olobardi, Dario, Lunardi, Claudio, Maule, Matteo, Delfino, Lorenzo, Triggiani, Massimo, Cardamone, Chiara, Benfaremo, Devis, Moroncini, Gianluca, Vacca, Angelo, Susca, Nicola, Gangemi, Sebastiano, Quattrocchi, Paola, Sticchi, Laura, Icardi, Giancarlo, Orsi, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Systemic sclerosis (SSc) is a rare autoimmune inflammatory rheumatic disease. The prevalence of SSc ranges from 7 to 700 cases per million worldwide. Due to multiple organ involvement and constant inflammatory state, this group of patients presents an increased risk of infectious diseases. This paper aimed to gather the up-to-date evidence on vaccination strategies for patients with SSc and to be a useful tool for the prevention and management of infectious diseases. The authors conducted a scoping review in which each paragraph presents data on a specific vaccine's safety, immunogenicity, and efficacy. The work deals with the following topics: SARS-CoV-2, seasonal influenza, , HAV, HBV, HZV, , , HPV, and diphtheria-tetanus-pertussis.
ISSN:2076-393X
2076-393X
DOI:10.3390/vaccines9121426